|Articles|May 1, 2016
May 2016: The Future of Hub Services: Higher Touch, Less Complexity
Author(s)Triplefin
As competition in a diversifying specialty drug business rises to fiver pitch, manufacturers are seeking new ways to differentiate the product servicing model to help their brands stand out. Triplefin's Hub-Lite™ program is adapting to these new expectations with a customized set of services geared to specialty's biggest growth segment: mid-range therapies with higher price tags than traditional retail pharmacy but significantly lower than high-end specialty pharma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
President Trump Set to Nominate Heidi Overton as FDA Commissioner
3
When Drug Pricing Becomes Trade Policy
4
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
5
